Alpha Tau Medical (DRTS) Other Accumulated Expenses (2020 - 2026)
Alpha Tau Medical's (DRTS) quarterly Other Accumulated Expenses came in at $5.5 million in Q1 2026, down 10.65% year-on-year from $6.2 million in Q1 2025, and little changed quarter-over-quarter from $5.5 million in Q4 2025.
Alpha Tau Medical (DRTS) Other Accumulated Expenses (2020 - 2026) Analysis & Trends
Alpha Tau Medical has disclosed Other Accumulated Expenses across 7 years of filings, most recently posting $5.5 million for Q1 2026.
- Other Accumulated Expenses for Q1 2026 came in at $5.5 million, down 10.65% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.5 million (down 10.65% YoY), and the FY2025 annual result was $5.5 million, up 33.27% from the prior year.
- Other Accumulated Expenses came in at $5.5 million for Q1 2026 at Alpha Tau Medical, roughly flat from $5.5 million in the prior quarter.
- In the past five years, Other Accumulated Expenses ranged from a high of $6.2 million in Q1 2025 to a low of $1.6 million in Q2 2022.
- The 5-year median for Other Accumulated Expenses is $3.4 million (2024), against an average of $3.6 million.
- Across the five-year window, Other Accumulated Expenses dropped 29.86% in 2022 and jumped 77.47% in 2023, its largest moves.
- Alpha Tau Medical's Other Accumulated Expenses stood at $2.2 million in 2022, then jumped by 54.67% to $3.5 million in 2023, then increased by 18.97% to $4.1 million in 2024, then surged by 33.27% to $5.5 million in 2025, then climbed by 0.38% to $5.5 million in 2026.
- The last three Other Accumulated Expenses figures came in at $5.5 million (Q1 2026), $5.5 million (Q4 2025), and $5.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | Alpha Tau Medical | 2,384.20 | -76.42 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.53 Mn |
| Dec 31, 2025 | 5.51 Mn |
| Sep 30, 2025 | 4.97 Mn |
| Jun 30, 2025 | 4.68 Mn |
| Mar 31, 2025 | 6.19 Mn |
| Dec 31, 2024 | 4.13 Mn |
| Sep 30, 2024 | 2.82 Mn |
| Jun 30, 2024 | 3.41 Mn |
| Mar 31, 2024 | 3.49 Mn |
| Dec 31, 2023 | 3.47 Mn |
| Sep 30, 2023 | 3.12 Mn |
| Jun 30, 2023 | 2.78 Mn |
| Mar 31, 2023 | 2.43 Mn |
| Dec 31, 2022 | 2.25 Mn |
| Sep 30, 2022 | 2.04 Mn |
| Jun 30, 2022 | 1.57 Mn |
| Mar 31, 2022 | 2.47 Mn |
| Dec 31, 2021 | 3.20 Mn |
| Dec 31, 2020 | 1.12 Mn |